SS
EBS icon

Sunbelt Securities’s Emergent Biosolutions EBS Stock Holding History

Sunbelt Securities’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108 Buy
13
+10
+333% +$104 ﹤0.01% 2635
2025
Q4 		$37 Hold
3
– – ﹤0.01% 2676
2025
Q3 		$26 Buy
+3
New +$23 ﹤0.01% 2641

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sunbelt Securities's EBS Position: Q1 2026 in Review

Sunbelt Securities increased its Emergent Biosolutions (EBS) stake by 333% in Q1 2026, buying an estimated $104 and bringing the position to 13 shares worth $108. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

Sunbelt Securities first reported a position in EBS in Q3 2025 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Sunbelt Securities held 13 shares of Emergent Biosolutions worth $108 as of Q1 2026.
  • Sunbelt Securities bought 10 Emergent Biosolutions shares in Q1 2026, an estimated $104.
  • Emergent Biosolutions made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2635 holding.
  • Sunbelt Securities first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.